ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 105

Awareness of Multisystem Inflammatory Syndrome in Children Among U.S. Parents: A Cross-Sectional Survey

Lyndsey Cole1, E. Adrianne Hammershaimb2, Yuanyuan Liang2, Megan Hendrich3, Dhiman Das3, Robert Petrin3, James Campbell2, Sean O'Leary1 and Jessica Cataldi1, 1University of Colorado School of Medicine, Denver, CO, 2University of Maryland School of Medicine, Baltimore, MD, 3Ipsos US Public Affairs, Washington, DC

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: COVID-19, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, March 31, 2023

Title: Posters: Clinical and Therapeutic II

Session Type: Poster Session B

Session Time: 5:00PM-6:00PM

Background/Purpose: Little is known about parental awareness of multisystem inflammatory syndrome in children (MIS-C), a rare but severe sequela of SARS-CoV-2 infection. We sought to describe parental knowledge of and attitudes toward MIS-C, identify demographic variables associated with knowledge of MIS-C, and assess associations with parents perceived COVID-19 disease severity and susceptibility in children.

Methods: Via a nationally representative, cross-sectional survey of U.S. parents conducted via Ipsos KnowledgePanel® from October-November 2021, we used bivariate and multivariable analyses to identify correlates of MIS-C awareness and examine associations with perceived COVID-19 severity and susceptibility.

Results: Survey response rate was 64.2% (3,230/5,034). Thirty-two percent of respondents had heard of MIS-C. After adjustment, higher educational level (compared to high school degree, “some college” Odds Ratio [OR]=2.00 [95% confidence interval 1.44,2.77]; “bachelor’s degree or higher” OR=3.14 [2.26,4.35]), being a healthcare worker (OR=1.82 [1.37,2.42]), having a child with a chronic medical condition (OR=1.62 [1.22,2.14]), and experience with more severe COVID-19 (OR=1.46 [1.14,1.86]) were associated with MIS-C awareness. Respondents with a child aged 12-17 years were less likely to be aware of MIS-C compared to those without (OR=0.78 [0.63,0.96]), as were male respondents (OR=0.56 [0.46,0.69],) and respondents aged 18-34 years (OR=0.72 [0.54,0.94]) compared to 35-44. Awareness of MIS-C was associated with higher perceived COVID-19 severity and susceptibility (regression coefficients 0.18 [0.10,0.25], p< 0.001 and 0.19 [0.11,0.28], p< 0.001, respectively).

Conclusion: This survey highlights the need to increase parental awareness of MIS-C. Future studies should explore how education regarding MIS-C as a complication of SARS-CoV-2 infection could improve understanding of pediatric disease severity and susceptibility.

Supporting image 1Table 1: Bivariate Analysis of Characteristics Associated with Awareness of MIS-C Among All Respondents

Supporting image 2Table 2: Unadjusted Effect of Awareness of MIS-C on Perceived COVID_19 Susceptibility and Severity Among All Respondents and By Age Group of Children


Disclosures: L. Cole: None; E. Hammershaimb: Moderna, 5, Novavax, 5; Y. Liang: None; M. Hendrich: None; D. Das: None; R. Petrin: None; J. Campbell: Moderna, 5, Novavax, 5; S. O'Leary: None; J. Cataldi: None.

To cite this abstract in AMA style:

Cole L, Hammershaimb E, Liang Y, Hendrich M, Das D, Petrin R, Campbell J, O'Leary S, Cataldi J. Awareness of Multisystem Inflammatory Syndrome in Children Among U.S. Parents: A Cross-Sectional Survey [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/awareness-of-multisystem-inflammatory-syndrome-in-children-among-u-s-parents-a-cross-sectional-survey/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/awareness-of-multisystem-inflammatory-syndrome-in-children-among-u-s-parents-a-cross-sectional-survey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology